Treatment of unacceptable bleeding in long-term users of 52-mg levonorgestrel intrauterine device: a prospective observational studyAJOG Global Reports at a Glance

BACKGROUND: In the first month after the insertion of the 52-mg levonorgestrel intrauterine device, irregular vaginal bleeding often occurs. In 6% to 18% of 52-mg levonorgestrel intrauterine device users, irregular vaginal bleeding reoccurs or continues for more than 6 months after insertion of the...

Full description

Saved in:
Bibliographic Details
Main Authors: Patty A.H.H. van der Heijden, MD, Karlijn A. Röttgering, Tamara J. Oderkerk, MD, Jeanne P. Dieleman, Arianne C. Lim, PhD, Marlies Y. Bongers, PhD, Peggy M.A.J. Geomini, PhD
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:AJOG Global Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666577825000358
Tags: Add Tag
No Tags, Be the first to tag this record!